6 months with fin 1mg and min foam
    7/12/2026

    From the encyclopedia
    Minoxidil →

    Vasodilator used on the scalp and, at low doses, as a tablet

    Finasteride →

    Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💧 Minoxidil (topical) foam once a day initially, now 3 times a week 6 months
    💊 Finasteride (oral) 1mg daily 6 months
    💧 Dr. For Hair shampoo (topical) 5 months
    the tone is 😀 positive with happy with progress results.

    Other terms

    The user is happy with hair growth progress after using minoxidil foam and 1mg finasteride for over six months, despite initial scalp itching. They are considering switching to oral minoxidil for faster growth and are concerned about maintaining consistency with the foam application.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results

      research Akkermansia muciniphila promotes testosterone‐mediated hair growth inhibition in mice

      October 2023 in “FASEB bioAdvances”
      This study investigated the effects of Akkermansia muciniphila on testosterone-induced hair growth inhibition in mice, finding that both live and pasteurized forms significantly encouraged hair growth and increased hair follicle size and growth factor levels compared to testosterone treatment alone.

      research Proceedings of the Ninth World Congress for Hair Research (2015)

      January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”
      This report discusses the Ninth World Congress for Hair Research and highlights the potential of hair follicle studies to advance understanding of various diseases, with no new clinical results presented.

      research Novel agents for the treatment of alopecia

      29 citations , December 1998 in “Seminars in Cutaneous Medicine and Surgery”
      This review examines recent approvals and emerging treatments for androgenetic alopecia, discussing newly approved drugs like Propecia and Rogaine Extra Strength 5%, but without presenting new clinical results.

      research Alopecia areata

      February 2023 in “Journal of vaccines and immunology”
      This article reviews the clinical features and potential associated conditions of alopecia areata, including its progression and histopathological characteristics, but reports no new clinical findings.